The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids

Table 3

Cases reported focusing on mirogabalin.

No.	Subject	Disease	Drug dose	Drug treatment	Treatment-related results
1	77 years (woman)	Lung carcinoma	10 mg/day	6 weeks	Mirogabalin-induced neutropenia
2	48 years (female)	Trigeminal neuralgia	2.5 mg/d	3 days	Mirogabalin-induced dizziness and drowsiness
3	89 years (female)	Trigeminal trophic syndrome	2.5 to 7.5 mg BID	Unknown	NRS from 5/10 to 1/10
4	73 years (man)	Neuropathic itch	10 mg/d	2 weeks	NRS from 9/10 to 1/10